Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kamryn Eddy, Ph.D.

Co-Author

This page shows the publications co-authored by Kamryn Eddy and Anne Klibanski.
Connection Strength

2.172
  1. Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa: A Randomized Clinical Trial. J Clin Psychiatry. 2018 Jan/Feb; 79(1).
    View in: PubMed
    Score: 0.185
  2. Macronutrient intake associated with weight gain in adolescent girls with anorexia nervosa. Int J Eat Disord. 2017 09; 50(9):1050-1057.
    View in: PubMed
    Score: 0.178
  3. Correction: Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. J Clin Psychiatry. 2015 05; 76(5):666.
    View in: PubMed
    Score: 0.154
  4. Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type. J Clin Psychiatry. 2015 Jan; 76(1):19-24.
    View in: PubMed
    Score: 0.151
  5. Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry. 2013 Aug; 74(8):e765-71.
    View in: PubMed
    Score: 0.136
  6. Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. J Clin Psychiatry. 2013 May; 74(5):e451-7.
    View in: PubMed
    Score: 0.134
  7. Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J Clin Endocrinol Metab. 2012 Oct; 97(10):E1898-908.
    View in: PubMed
    Score: 0.128
  8. Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol (Oxf). 2012 Apr; 76(4):520-5.
    View in: PubMed
    Score: 0.124
  9. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol. 2011 Feb; 164(2):253-61.
    View in: PubMed
    Score: 0.113
  10. Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial. J Bone Miner Res. 2021 11; 36(11):2116-2126.
    View in: PubMed
    Score: 0.060
  11. Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa. J Clin Endocrinol Metab. 2021 06 16; 106(7):2021-2035.
    View in: PubMed
    Score: 0.059
  12. Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial. J Bone Miner Res. 2020 02; 35(2):248-260.
    View in: PubMed
    Score: 0.053
  13. A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa. J Clin Endocrinol Metab. 2019 10 01; 104(10):4347-4355.
    View in: PubMed
    Score: 0.052
  14. Differences in Trabecular Plate and Rod Structure in Premenopausal Women Across the Weight Spectrum. J Clin Endocrinol Metab. 2019 10 01; 104(10):4501-4510.
    View in: PubMed
    Score: 0.052
  15. Disrupted Oxytocin-Appetite Signaling in Females With Anorexia Nervosa. J Clin Endocrinol Metab. 2019 10 01; 104(10):4931-4940.
    View in: PubMed
    Score: 0.052
  16. Endogenous Oxytocin Levels in Relation to Food Intake, Menstrual Phase, and Age in Females. J Clin Endocrinol Metab. 2019 04 01; 104(4):1348-1356.
    View in: PubMed
    Score: 0.051
  17. Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder. Clin Endocrinol (Oxf). 2019 06; 90(6):789-797.
    View in: PubMed
    Score: 0.051
  18. Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial. Br J Sports Med. 2019 Feb; 53(4):229-236.
    View in: PubMed
    Score: 0.049
  19. Bone Parameters in Anorexia Nervosa and Athletic Amenorrhea: Comparison of Two Hypothalamic Amenorrhea States. J Clin Endocrinol Metab. 2018 06 01; 103(6):2392-2402.
    View in: PubMed
    Score: 0.048
  20. Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum. Neuropsychopharmacology. 2018 05; 43(6):1436-1444.
    View in: PubMed
    Score: 0.046
  21. Erratum to: Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. Int J Eat Disord. 2017 10; 50(10):1239.
    View in: PubMed
    Score: 0.045
  22. Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum. J Clin Endocrinol Metab. 2017 08 01; 102(8):2814-2824.
    View in: PubMed
    Score: 0.045
  23. Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. Int J Eat Disord. 2017 Apr; 50(4):359-369.
    View in: PubMed
    Score: 0.044
  24. Vertebral Volumetric Bone Density and Strength Are Impaired in Women With Low-Weight and Atypical Anorexia Nervosa. J Clin Endocrinol Metab. 2017 01 01; 102(1):57-68.
    View in: PubMed
    Score: 0.043
  25. Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord. 2017 Apr; 50(4):343-351.
    View in: PubMed
    Score: 0.042
  26. Vertebral Strength and Estimated Fracture Risk Across the BMI Spectrum in Women. J Bone Miner Res. 2016 Feb; 31(2):281-8.
    View in: PubMed
    Score: 0.040
  27. Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women. J Clin Endocrinol Metab. 2014 Dec; 99(12):4664-73.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.